An Observational Study of Multiple Sclerosis (MS) Patients Starting or Restarting Baseline Treatment With Interferon Beta 1a After the Use of Escalation Treatment With Mitoxantrone

Clinical trial NCT01142518 · COMPLETED

Trial details

NCT number: NCT01142518
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing-Remitting Multiple Sclerosis

Start date: 2005-07-01
Primary completion: 2009-03-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.